miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Br

miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells

Related Keywords

New York ,United States ,Germany ,Rockville ,Becs ,Wien ,Austria ,France ,Joan Massagu ,Cedarlane Tebu Bio ,Laboratory Memorial Sloan Kettering Cancer Center ,Image Lab ,Leading Malignancy ,Reactive Medicine ,Preventive Approach ,Advance Management ,Metastatic Breast ,Marker Based Targeted Therapy ,Potential Strategy ,Memorial Sloan Kettering Cancer Center ,American Type Culture Collection ,Modified Eagle ,World Precision Instruments ,Script Inhibitor Negative Control ,Allstars Negative Control ,Santa Cruz ,Micro Kit ,Thermo Fisher Scientific ,Strand Kit ,Script Primer Assay ,Varioskan Flash ,Expression Vector ,Re Porter Assay System ,Molecular Target ,Targeted Prevention ,Junction Associated Molecules ,Key Regulators ,Potential Biomarkers ,